Screener
KRE vs XPH
State Street SPDR S&P Regional Banking ETF vs State Street SPDR S&P Pharmaceuticals ETF
Key differences
- KRE is significantly larger than XPH — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, KRE has delivered higher annualized returns.
Side-by-side comparison
| KRE | XPH | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $4.2B | $355M |
| Since | 2006 | 2006 |
| Dividend yield | 2.25% | 0.65% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +26.5% | +47.4% |
| CAGR 3Y | +24.7% | +14.1% |
| CAGR 5Y | +2.7% | +4.7% |
| Sharpe 3Y | 0.79 | 0.58 |
| Volatility 1Y | 23.30% | 21.28% |
| Max drawdown | -55.03% | -35.96% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KRE and XPH
Explore further